Search Results - "EIFRIG, B."

The impact of a specific aqua-training for adult haemophilic patients - results of the WATERCISE study (WAT-QoL) by Von MACKENSEN, S., EIFRIG, B., ZÄCH, D., KALNINS, J., WIELOCH, A., ZELLER, W.

“…Sport is increasingly recommended for haemophilic patients due to physical and psychological benefits. ‘WATERCISE’ is a specific aqua‐training programme for…”
Get full text

Experimental metastasis and primary tumor growth in mice with hemophilia A by LANGER, F., AMIRKHOSRAVI, A., INGERSOLL, S. B., WALKER, J. M., SPATH, B., EIFRIG, B., BOKEMEYER, C., FRANCIS, J. L.

“…During experimental lung metastasis, tumor cells adhere to the pulmonary microvasculature and activate coagulation via surface‐expressed tissue factor (TF),…”
Get full text

Efficacy, safety and tolerability of recombinant factor VIII (REFACTO®) in patients with haemophilia A: interim data from a postmarketing surveillance study in Germany and Austria by POLLMANN, H., EXTERNEST, D., GANSER, A., EIFRIG, B., KREUZ, W., LENK, H., PABINGER, I., SCHRAMM, W., SCHWARZ, T. F., ZIMMERMANN, R., ZAVAZAVA, N., OLDENBURG, J., KLAMROTH, R.

“…An open‐label, multicentre, postmarketing surveillance study conducted in Germany and Austria with recombinant factor VIII (REFACTO®) has enrolled 217 patients…”
Get full text

Haemostatic aspects in clinical oncology by Langer, F, Holstein, K, Eifrig, B, Bokemeyer, C

“…The clinical link between cancer and thrombosis has been recognized by Armand Trousseau in 1865. It has now become clear that clotting activation in malignancy…”
Get more information

Inhibitor-Immunology-Study. Different HLA-types seem to be involved in the inhibitor development in haemophilia A by Wieland, I, Wermes, C, Eifrig, B, Holstein, K, Pollmann, H, Siegmund, B, Bidlingmaier, C, Kurnik, K, Nimtz-Talaska, A, Niekrens, C, Eisert, R, Tiede, A, Ebenebe, C, Lakomek, M, Hoy, L, Welte, K, Sykora, K-W

“…The development of inhibitors is one of the most important complications of replacement therapy in haemophilia, affecting mortality and morbidity. Inhibitor…”
Get more information

Inhibitor-immunology-study. Evaluation of inhibitor development in haemophilia B by Wieland, I, Wermes, C, Eifrig, B, Holstein, K, Pollmann, H, Siegmund, B, Eberl, W, Kemkes-Matthes, B, Bidlingmaier, C, Kurnik, K, Lischetzki, G, Nimtz-Talaska, A, Eisert, R, Bogdanova, N, Doerk, T, Sykora, K-W

“…The development of inhibitors in haemophilia B is one of the most important complications of replacement therapy, affecting mortality and morbidity. Inhibitor…”
Get more information

Rate control for MPEG transcoders by Limin Wang, Luthra, A., Eifrig, B.

“…In MPEG, the input pictures can be coded in three different types: I, P, and B. The three pictures require quite different numbers of bits because of different…”
Get full text

Exacerbation of antiphospholipid antibody syndrome after treatment of localized cancer: a report of two cases by LANGER, F, EIFRIG, B, MARX, G, STORK, A, HEGEWISCH-BECKER, S, HOSSFELD, D. K

“…Patients with malignancy often present with a variety of coagulation abnormalities which may ultimately lead to recurrent arterial and venous thromboses…”
Get full text

Non-overt disseminated intravascular coagulation in patients during treatment with antithymocyte globulin for unrelated allogeneic hematopoietic stem cell transplantation by WEBER, M, KRÖGER, N, LANGER, F, HANSEN, A, ZABELINA, T, EIFRIG, B, HOSSFELD, D. K, ZANDER, A. R

“…We assessed the effect of rabbit antithymocyte globulin manufactured by Fresenius (ATG-F) on the hemostatic system in patients (n=12) with various…”
Get full text

Enhanced platelet aggregation with TRAP-6 and collagen in platelet aggregometry in patients with venous thromboembolism by Weber, M, Gerdsen, F, Gutensohn, K, Schoder, V, Eifrig, B, Hossfeld, D.K

“…The role of platelet hyperaggregability as a possible risk factor for venous thromboembolism is not well defined. Some authors described enhanced maximal…”
Get full text

Platelet function testing in apheresis products: flow cytometric, resonance thrombographic (RTG) and rotational thrombelastographic (roTEG) analyses by Gutensohn, K., Geidel, K., Kroeger, N., Eifrig, B., Crespeigne, N., Kuehnl, P.

“…During storage of platelet concentrates, quality control of the units is mandatory. This includes the important testing of the hemostatic function of…”
Get full text

Thromboembolische Komplikationen – Prophylaxe und Therapie im Fokus by Langer, F., Holstein, K., Eifrig, B., Bokemeyer, C.

“…Zusammenfassung Krebspatienten haben ein erhöhtes Risiko für thromboembolische Komplikationen, die gemeinhin unter dem Begriff des Trousseau-Syndroms…”
Get full text

Biocompatibility of a new cell separator studied by flow cytometry: analyses of platelet antigens during apheresis and storage by Gutensohn, K., Alisch, A., Crespeigne, N., Eifrig, B., Kuehnl, P.

“…BACKGROUND: Alterations of platelet antigens are known to occur during cytapheresis and storage. These changes have been shown to be dependent on the…”
Get full text

Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene by HERRMANN, F. H., WULFF, K., AUERSWALD, G., SCHULMAN, S., ASTERMARK, J., BATOROVA, A., KREUZ, W., POLLMANN, H., RUIZ-SAEZ, A., DE BOSCH, N., SALAZAR-SANCHEZ, L.

“…The congenital FVII deficiency (FVIID) is a rare haemorrhagic disorder with an autosomal recessive pattern of inheritance. Data on phenotype and the genotype…”
Get full text

Clinical phenotypes and factor VII genotype in congenital factor VII deficiency by Mariani, Guglielmo, Herrmann, Falko H, Dolce, Alberto, Batorova, Angelika, Etro, Daniela, Peyvandi, Flora, Wulff, Karin, Schved, Jean F, Auerswald, Günter, Ingerslev, Jorgen, Bernardi, Francesco

“…To investigate the relationship between clinical phenotype, clotting activity (FVIIc) and FVII genotype, a multi-center study of factor VII (FVII) congenital…”
Get more information

Factor X deficiency: clinical manifestation of 102 subjects from Europe and Latin America with mutations in the factor 10 gene by HERRMANN, F. H., AUERSWALD, G., RUIZ-SAEZ, A., NAVARRETE, M., POLLMANN, H., LOPACIUK, S., BATOROVA, A., WULFF, K.

“…Inherited factor X deficiency (FXD) is a rare (1:1 000 000) recessive bleeding disorder. The clinical and laboratory phenotypes of FXD are poorly correlated…”
Get full text

Haemophilia treatment centres in Germany by Zimmermann, R, Eifrig, B, Lenk, H, Pollmann, H, Scharrer, I, Huth-Kühne, A

“…An adequate number of qualified haemophilia centres is an essential requirement for effective and cost-efficient haemophilia care. During a reassessment of the…”
Get more information

An in vitro study on the mechanisms of coagulation activation in acute myelogenous leukemia (AML): role of tissue factor regulation by cytotoxic drugs and GM-CSF by Langer, Florian, Amirkhosravi, Ali, Loges, Sonja, Meyer, Todd, Eifrig, Barbara, Hossfeld, Dieter K, Fiedler, Walter, Francis, John L

“…AML patients may suffer from a disseminated coagulopathy, which can aggravate a pre-existing bleeding tendency due to thrombocytopenia and platelet…”
Get more information

Thrombophiliefaktoren als Auslöser retinaler Gefässverschlüsse by LERCHE, R.-C, WILHELM, C, EIFRIG, B, RICHARD, G

Get full text

Recurrent deep-vein thrombosis based on homozygous factor V Leiden mutation acquired after liver transplantation by Willems, Marc, Sterneck, Martina, Langer, Florian, Jung, Roman, Haddad, Munif, Hagel, Christian, Kuetemeier, Robert, Eifrig, Barbara, Broering, Dieter, Fischer, Lutz, Rogiers, Xavier

“…Several genetic liver diseases can be treated by liver transplantation (LT). However, some genetic defects also may be acquired by this procedure. We describe…”
Get full text